Developer docs
API playgroundTry for free, no card

Search company profiles

Farmhispania Group

Full company profile

uuid002dsl6

Namestring
Farmhispania Group
Legal namestring
FARMHISPANIA, S.A., FARMHISPANIA GROUP, S.L. and ROLABO OUTSOURCING, S.L.
Company typeenum
Private
Founded yearint
1974
Descriptiontext

Farmhispania Group is a privately held Spanish pharmaceutical company founded in 1974, operating as a leading European Contract Development and Manufacturing Organization (CDMO) and supplier of generic Active Pharmaceutical Ingredients (APIs). The group comprises three co-responsible legal entities headquartered in Montmeló, Barcelona, with a second manufacturing site in Zaragoza operated through its wholly-owned subsidiary Rolabo Outsourcing, S.L. Its core technology centers on the manufacture of highly potent active pharmaceutical ingredients (HPAPIs), high-potency fermentation for biomolecules, and development of antibody-drug conjugates (ADCs) for oncology applications, supported by five R&D laboratories and more than 60 scientists.

The company generates revenue through two streams: long-term contract development and manufacturing services (CDMO) sold directly to pharmaceutical clients, and product sales of generic APIs under regulatory approvals including CEP, FDA, and ANVIA. Customer acquisition is driven by a dedicated Business Development unit, direct commercial outreach, and participation at major industry trade shows (CPhI, DCAT, BioEurope). Its customer base consists of pharmaceutical companies requiring regulatory-compliant, high-containment API manufacturing and supply continuity for critical medicines, with Merck & Co. (MSD) identified as a recognized long-term partner.

Farmhispania's competitive position rests on a multi-jurisdictional regulatory record (five consecutive FDA inspections since 2006 with zero observations, plus ANVISA, PMDA, KFDA, and Russian Health Authority clearances), possession of the world's first EDQM CEP for Everolimus 2% BHT, and a recently expanded Montmeló facility featuring a new 8-floor, 3,200 m² multipurpose manufacturing building. The company is actively investing in ESG positioning (SBTi-approved targets, UN Global Compact membership) and capabilities in ADCs and biomolecules as next-generation growth vectors.

Short descriptiontext

Farmhispania Group is a privately held Spanish CDMO and generic API manufacturer founded in 1974, operating two GMP FDA-inspected sites in Montmeló and Zaragoza. It specializes in HPAPIs, high-potency fermentation, and antibody-drug conjugates, supplying global pharmaceutical companies with regulatory-cleared APIs and contract manufacturing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Active pharmaceutical ingredients, Contract manufacturing services, High potency APIs, Generic API manufacturing, Pharmaceutical CDMO services
Industry3 codes
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAHAC
High-Potency API (HPAPI) Development & Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical and Medicine Manufacturing3254
  • Medicinal and Botanical Manufacturing325411
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical API Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CDMO (Contract Development and Manufacturing Services)
TypeProfessional Services
Description

Contract manufacturing services for pharmaceutical companies requiring development and production of APIs, including HPAPI and fermentation-based products. Services include process development, scale-up, and GMP manufacturing under long-term contracts with pharmaceutical clients.

farmhispaniagroup.com
2Generic Active Pharmaceutical Ingredients (APIs)
TypeOne Time License
Description

Manufacture and sale of generic APIs to pharmaceutical companies worldwide. Revenue is generated through product sales under established regulatory approvals (CEP, FDA, ANVISA).

farmhispaniagroup.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1B2B contract manufacturing and generic API supply — pricing negotiated per engagement.
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing is available. Customer contracts are negotiated directly with the Business Development and Sales departments.

farmhispaniagroup.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Farmhispania Group manufactures and sells Active Pharmaceutical Ingredients (APIs), including generic APIs such as Metformin HCl, and provides Contract Development and Manufacturing Organization (CDMO) services for pharmaceutical companies. The company specializes in High Potency Active Pharmaceutical Ingredients (HPAPIs), high-potency fermentation-based biomolecule production, and antibody-drug conjugate (ADC) synthesis process development. Manufacturing is conducted at two GMP-compliant, FDA-inspected production sites in Spain, with research and process development supported by five R&D laboratories and more than 60 scientists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • First CEP for Everolimus 2% BHT issued by EDQM — first time a CEP for Everolimus has been issued to any company.
Product overview1 text field

Farmhispania Group is a leading European CDMO (Contract Development and Manufacturing Organization) specializing in Active Pharmaceutical Ingredients (APIs). The company operates two GMP FDA-inspected manufacturing sites in Spain (Montmeló-Barcelona and Zaragoza) and offers an integrated portfolio comprising: CDMO services for custom development and manufacturing, Generic APIs (including Metformin HCl), HPAPI (Highly Potent Active Pharmaceutical Ingredients) technologies, and Fermentation capabilities for biologics. Key products include Everolimus 2% BHT (first CEP issued worldwide) and ADC (Antibody-Drug Conjugates) for cancer therapy. The company leverages 5 R&D laboratories with over 60 scientists to support its manufacturing operations.

Product and service6 records
1CDMO (Contract Development and Manufacturing Organization) Services
CategoryContract Manufacturing Services
Description

End-to-end contract development and manufacturing services for active pharmaceutical ingredients, offering R&D, process development, scale-up, and GMP-compliant commercial production to pharmaceutical companies requiring external manufacturing partners.

2Generic APIs (Active Pharmaceutical Ingredients)
CategoryGeneric APIs
Description

Generic Active Pharmaceutical Ingredients, including Metformin HCl, manufactured under GMP conditions for sale to pharmaceutical companies worldwide under established regulatory approvals (CEP, FDA DMF, ANVISA).

3HPAPI (Highly Potent Active Pharmaceutical Ingredients) Manufacturing
CategoryHPAPI Manufacturing
Description

Specialized manufacturing of Highly Potent Active Pharmaceutical Ingredients for oncology and other targeted therapies requiring specialized containment, handling, and regulatory-grade production capabilities.

4High Potency Fermentation Services
CategoryBiologics Manufacturing
Description

Fermentation-based manufacturing services for the production of biologics, biomolecules, and biological entities for therapeutic and diagnostic applications in humans.

5Everolimus 2% BHT API
CategoryGeneric APIs
Description

Everolimus 2% BHT, an Active Pharmaceutical Ingredient for which Farmhispania Group received the first-ever Certificate of Suitability (CEP) from EDQM, making it the first company worldwide to hold a CEP for Everolimus.

6ADC (Antibody-Drug Conjugate) Development and Synthesis Optimization
CategoryADC Development
Description

Development and optimization of synthesis processes for therapeutic monoclonal antibodies conjugated to cytotoxic chemical drugs (ADCs), used in targeted cancer therapy applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

Farmhispania Group formally joined the United Nations Global Compact in May 2026, committing to the UN's ten principles covering human rights, labour, environment, and anti-corruption.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-28
Description

Farmhispania Group received approval of its Science Based Targets (SBTs) by the Science Based Targets initiative in April 2025, committing to science-aligned greenhouse gas emission reduction targets.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss CDMO with strong HPAPI and ADC development capabilities. Direct peer in high-potency API manufacturing and antibody-drug conjugate process development for global pharma customers.

TypeDirect peer
Description

Portuguese-headquartered CDMO specializing in HPAPI, particle engineering, and API manufacturing with multiple FDA-inspected sites. Directly comparable as a European HPAPI and contract API CDMO serving global pharma.

3Recipharm
TypeBroad incumbent
Description

Swedish-headquartered CDMO with broad API and finished dose services across Europe. Comparable as a larger European CDMO with overlapping generic and contract API offerings.

TypeBroad incumbent
Description

European API specialist spun out of Sanofi with broad small-molecule and HPAPI capabilities. Comparable as a Europe-based commercial API manufacturer with CDMO ambitions overlapping Farmhispania's offerings.

TypeBroad incumbent
Description

German pharmaceutical CDMO with API and finished dose capabilities. Comparable as a European mid-market CDMO serving global pharma with similar scale and regulatory footprint.

TypeBroad incumbent
Description

Global specialty chemicals group with an HPAPI and drug development CDMO business. Comparable as a larger incumbent offering HPAPI and complex API services with global scale.

7Olon Group
TypeDirect peer
Description

Italian CDMO and generic API manufacturer with fermentation and HPAPI capabilities. Highly comparable to Farmhispania on European generic API supply plus CDMO services for HPAPI and biologics.

TypeBroad incumbent
Description

Swiss-listed CDMO with broad API and finished dose manufacturing services across multiple sites. Comparable as a larger European CDMO competitor with overlapping API manufacturing capabilities.

TypeDirect peer
Description

European API manufacturer with HPAPI and complex chemistry capabilities. Comparable as a European mid-sized API specialist competing for similar HPAPI and small-molecule CDMO contracts.

TypeBroad incumbent
Description

European CDMO offering APIs, peptides, lipids, and injectables manufacturing. Comparable as a larger, more diversified CDMO competing for HPAPI and complex API programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Farmhispania Group

Pharmaceutical API Manufacturingfarmhispaniagroup.com

Farmhispania Group is a privately held Spanish CDMO and generic API manufacturer founded in 1974, operating two GMP FDA-inspected sites in Montmeló and Zaragoza. It specializes in HPAPIs, high-potency fermentation, and antibody-drug conjugates, supplying global pharmaceutical companies with regulatory-cleared APIs and contract manufacturing services.

What Farmhispania Group does

Farmhispania Group is a privately held Spanish pharmaceutical company founded in 1974, operating as a leading European Contract Development and Manufacturing Organization (CDMO) and supplier of generic Active Pharmaceutical Ingredients (APIs). The group comprises three co-responsible legal entities headquartered in Montmeló, Barcelona, with a second manufacturing site in Zaragoza operated through its wholly-owned subsidiary Rolabo Outsourcing, S.L. Its core technology centers on the manufacture of highly potent active pharmaceutical ingredients (HPAPIs), high-potency fermentation for biomolecules, and development of antibody-drug conjugates (ADCs) for oncology applications, supported by five R&D laboratories and more than 60 scientists.

The company generates revenue through two streams: long-term contract development and manufacturing services (CDMO) sold directly to pharmaceutical clients, and product sales of generic APIs under regulatory approvals including CEP, FDA, and ANVIA. Customer acquisition is driven by a dedicated Business Development unit, direct commercial outreach, and participation at major industry trade shows (CPhI, DCAT, BioEurope). Its customer base consists of pharmaceutical companies requiring regulatory-compliant, high-containment API manufacturing and supply continuity for critical medicines, with Merck & Co. (MSD) identified as a recognized long-term partner.

Farmhispania's competitive position rests on a multi-jurisdictional regulatory record (five consecutive FDA inspections since 2006 with zero observations, plus ANVISA, PMDA, KFDA, and Russian Health Authority clearances), possession of the world's first EDQM CEP for Everolimus 2% BHT, and a recently expanded Montmeló facility featuring a new 8-floor, 3,200 m² multipurpose manufacturing building. The company is actively investing in ESG positioning (SBTi-approved targets, UN Global Compact membership) and capabilities in ADCs and biomolecules as next-generation growth vectors.

Farmhispania Group firmographics

Firmographics
Name
Farmhispania Group
Legal name
FARMHISPANIA, S.A., FARMHISPANIA GROUP, S.L. and ROLABO OUTSOURCING, S.L.
Website
https://farmhispaniagroup.com
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
251–500 employees
Short description
Farmhispania Group is a privately held Spanish CDMO and generic API manufacturer founded in 1974, operating two GMP FDA-inspected sites in Montmeló and Zaragoza. It specializes in HPAPIs, high-potency fermentation, and antibody-drug conjugates, supplying global pharmaceutical companies with regulatory-cleared APIs and contract manufacturing services.
Ownership category
akta.pro rank

Farmhispania Group industry classification

Industry
Product category
Pharmaceutical API Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAHAC
High-Potency API (HPAPI) Development & Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Active pharmaceutical ingredients
  • Contract manufacturing services
  • High potency APIs
  • Generic API manufacturing
  • Pharmaceutical CDMO services

Where Farmhispania Group is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Farmhispania Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. CDMO (Contract Development and Manufacturing Services): Contract manufacturing services for pharmaceutical companies requiring development and production of APIs, including HPAPI and fermentation-based products. Services include process development, scale-up, and GMP manufacturing under long-term contracts with pharmaceutical clients.
  2. Generic Active Pharmaceutical Ingredients (APIs): Manufacture and sale of generic APIs to pharmaceutical companies worldwide. Revenue is generated through product sales under established regulatory approvals (CEP, FDA, ANVISA).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B contract manufacturing and generic API supply — pricing negotiated per engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Farmhispania Group product offering

Product offering

Core offering

Farmhispania Group manufactures and sells Active Pharmaceutical Ingredients (APIs), including generic APIs such as Metformin HCl, and provides Contract Development and Manufacturing Organization (CDMO) services for pharmaceutical companies. The company specializes in High Potency Active Pharmaceutical Ingredients (HPAPIs), high-potency fermentation-based biomolecule production, and antibody-drug conjugate (ADC) synthesis process development. Manufacturing is conducted at two GMP-compliant, FDA-inspected production sites in Spain, with research and process development supported by five R&D laboratories and more than 60 scientists.

Product overview

Farmhispania Group is a leading European CDMO (Contract Development and Manufacturing Organization) specializing in Active Pharmaceutical Ingredients (APIs). The company operates two GMP FDA-inspected manufacturing sites in Spain (Montmeló-Barcelona and Zaragoza) and offers an integrated portfolio comprising: CDMO services for custom development and manufacturing, Generic APIs (including Metformin HCl), HPAPI (Highly Potent Active Pharmaceutical Ingredients) technologies, and Fermentation capabilities for biologics. Key products include Everolimus 2% BHT (first CEP issued worldwide) and ADC (Antibody-Drug Conjugates) for cancer therapy. The company leverages 5 R&D laboratories with over 60 scientists to support its manufacturing operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • CDMO (Contract Development and Manufacturing Organization) Services End-to-end contract development and manufacturing services for active pharmaceutical ingredients, offering R&D, process development, scale-up, and GMP-compliant commercial production to pharmaceutical companies requiring external manufacturing partners.
  • Generic APIs (Active Pharmaceutical Ingredients) Generic Active Pharmaceutical Ingredients, including Metformin HCl, manufactured under GMP conditions for sale to pharmaceutical companies worldwide under established regulatory approvals (CEP, FDA DMF, ANVISA).
  • HPAPI (Highly Potent Active Pharmaceutical Ingredients) Manufacturing Specialized manufacturing of Highly Potent Active Pharmaceutical Ingredients for oncology and other targeted therapies requiring specialized containment, handling, and regulatory-grade production capabilities.
  • High Potency Fermentation Services Fermentation-based manufacturing services for the production of biologics, biomolecules, and biological entities for therapeutic and diagnostic applications in humans.
  • Everolimus 2% BHT API Everolimus 2% BHT, an Active Pharmaceutical Ingredient for which Farmhispania Group received the first-ever Certificate of Suitability (CEP) from EDQM, making it the first company worldwide to hold a CEP for Everolimus.
  • ADC (Antibody-Drug Conjugate) Development and Synthesis Optimization Development and optimization of synthesis processes for therapeutic monoclonal antibodies conjugated to cytotoxic chemical drugs (ADCs), used in targeted cancer therapy applications.

Quantifiable outcome

  • First CEP for Everolimus 2% BHT issued by EDQM — first time a CEP for Everolimus has been issued to any company.

Companies that use Farmhispania Group

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Farmhispania Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Farmhispania Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • UN Global CompactcoreStrategic or Co-development Partner · 13 May 2026Farmhispania Group formally joined the United Nations Global Compact in May 2026, committing to the UN's ten principles covering human rights, labour, environment, and anti-corruption.
  • Science Based Targets initiative (SBTi)coreStrategic or Co-development Partner · 28 April 2025Farmhispania Group received approval of its Science Based Targets (SBTs) by the Science Based Targets initiative in April 2025, committing to science-aligned greenhouse gas emission reduction targets.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Farmhispania Group competitors and assessment

Company assessment

Direct peers

  • Carbogen Amcis: Swiss CDMO with strong HPAPI and ADC development capabilities. Direct peer in high-potency API manufacturing and antibody-drug conjugate process development for global pharma customers.
  • Hovione: Portuguese-headquartered CDMO specializing in HPAPI, particle engineering, and API manufacturing with multiple FDA-inspected sites. Directly comparable as a European HPAPI and contract API CDMO serving global pharma.
  • Olon Group: Italian CDMO and generic API manufacturer with fermentation and HPAPI capabilities. Highly comparable to Farmhispania on European generic API supply plus CDMO services for HPAPI and biologics.
  • PharmaZell (formerly Novasep CDMO): European API manufacturer with HPAPI and complex chemistry capabilities. Comparable as a European mid-sized API specialist competing for similar HPAPI and small-molecule CDMO contracts.

Broad incumbents

  • Recipharm: Swedish-headquartered CDMO with broad API and finished dose services across Europe. Comparable as a larger European CDMO with overlapping generic and contract API offerings.
  • EUROAPI: European API specialist spun out of Sanofi with broad small-molecule and HPAPI capabilities. Comparable as a Europe-based commercial API manufacturer with CDMO ambitions overlapping Farmhispania's offerings.
  • Aenova Group: German pharmaceutical CDMO with API and finished dose capabilities. Comparable as a European mid-market CDMO serving global pharma with similar scale and regulatory footprint.
  • Johnson Matthey (Pharma Services / Particle Sciences): Global specialty chemicals group with an HPAPI and drug development CDMO business. Comparable as a larger incumbent offering HPAPI and complex API services with global scale.
  • Siegfried Holding: Swiss-listed CDMO with broad API and finished dose manufacturing services across multiple sites. Comparable as a larger European CDMO competitor with overlapping API manufacturing capabilities.
  • CordenPharma: European CDMO offering APIs, peptides, lipids, and injectables manufacturing. Comparable as a larger, more diversified CDMO competing for HPAPI and complex API programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Farmhispania Group social profiles

Digital presence

Farmhispania Group compliance and trust

Trust signal

Compliance11 records

Farmhispania Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Farmhispania Group leadership team

Management profile

Number of profiles

Profiles1 record

Farmhispania Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Farmhispania Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Farmhispania Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmhispania Group

What does Farmhispania Group do?

Farmhispania Group manufactures and sells Active Pharmaceutical Ingredients (APIs), including generic APIs such as Metformin HCl, and provides Contract Development and Manufacturing Organization (CDMO) services for pharmaceutical companies. The company specializes in High Potency Active Pharmaceutical Ingredients (HPAPIs), high-potency fermentation-based biomolecule production, and antibody-drug conjugate (ADC) synthesis process development. Manufacturing is conducted at two GMP-compliant, FDA-inspected production sites in Spain, with research and process development supported by five R&D laboratories and more than 60 scientists.

Is Farmhispania Group a public or private company?

Farmhispania Group is a private company. It is classified as private equity controlled and is currently operating.

When was Farmhispania Group founded?

Farmhispania Group was founded in 1974. It employs 251 to 500 people.

Where is Farmhispania Group based?

Farmhispania Group is headquartered in Barcelona, Spain, in the Europe region.

How does Farmhispania Group make money?

Two revenue lines are on record. CDMO (Contract Development and Manufacturing Services) is the primary driver. The others are generic Active Pharmaceutical Ingredients (APIs).

Who are Farmhispania Group's main competitors?

Direct peers on record are Carbogen Amcis, Hovione, Olon Group and PharmaZell (formerly Novasep CDMO). Broad incumbents are Recipharm, EUROAPI, Aenova Group, Johnson Matthey (Pharma Services / Particle Sciences), Siegfried Holding and CordenPharma.

Does Farmhispania Group have an API?

No public API is recorded for Farmhispania Group.

What industry is Farmhispania Group in?

Farmhispania Group's product category is Pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGAHAC, High-Potency API (HPAPI) Development & Manufacturing. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales